Edition:
United States

Bio Path Holdings Inc (BPTH.OQ)

BPTH.OQ on NASDAQ Stock Exchange Capital Market

0.96USD
4:00pm EDT
Change (% chg)

$-0.05 (-4.95%)
Prev Close
$1.01
Open
$0.94
Day's High
$0.99
Day's Low
$0.94
Volume
5,349
Avg. Vol
6,102
52-wk High
$5.85
52-wk Low
$0.93

Chart for

About

Bio-Path Holdings, Inc. is a clinical and preclinical stage oncology focused antisense drug development company. The Company utilizes a technology that achieves systemic delivery for target specific protein inhibition for any gene product that is over-expressed in disease. Its drug delivery and antisense technology, DNAbilize,... (more)
No analyst recommendations are available for .

Overall

Beta: 2.37
Market Cap(Mil.): $11.45
Shares Outstanding(Mil.): 11.34
Dividend: --
Yield (%): --

Financials

  BPTH.OQ Industry Sector
P/E (TTM): -- 107.68 32.65
EPS (TTM): -0.76 -- --
ROI: -121.16 1.61 12.72
ROE: -121.16 0.32 14.84

BRIEF-Bio-Path Holdings Reports Q1 Loss Per Share $0.17

* BIO-PATH HOLDINGS REPORTS FIRST QUARTER 2018 FINANCIAL RESULTS

May 16 2018

BRIEF-Bio-Path Holdings Reports Full Year 2017 Financial Results

* PATH HOLDINGS REPORTS FULL YEAR 2017 FINANCIAL RESULTS Source text for Eikon: Further company coverage:

Apr 03 2018

Competitors

Earnings vs. Estimates